G1 Therapeutics Inc logo

G1 Therapeutics Inc

7
NAS:GTHX (USA)  
$ 4.47 +0.18 (+4.2%) 11:09 PM EST
At Loss
P/B:
6.57
Market Cap:
$ 233.33M
Enterprise V:
$ 198.20M
Volume:
1.56M
Avg Vol (2M):
1.57M
Also Trade In:
Volume:
1.56M
At Loss
Avg Vol (2M):
1.57M

Business Description

Description
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy.
Name Current Vs Industry Vs History
Cash-To-Debt 1.47
Equity-to-Asset 0.29
Debt-to-Equity 1.58
Debt-to-EBITDA -1.63
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.9
Distress
Grey
Safe
Beneish M-Score -2.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 90.61
9-Day RSI 78.86
14-Day RSI 69.74
6-1 Month Momentum % 83.21
12-1 Month Momentum % -13.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.87
Quick Ratio 3.45
Cash Ratio 2.76
Days Inventory 743.24
Days Sales Outstanding 53.92
Days Payable 303.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.9
Shareholder Yield % 9.27

Financials (Next Earnings Date:2024-05-03 Est.)

GTHX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GTHX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

G1 Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 82.511
EPS (TTM) ($) -0.95
Beta 1.16
Volatility % 89.51
14-Day RSI 69.74
14-Day ATR ($) 0.35025
20-Day SMA ($) 3.6015
12-1 Month Momentum % -13.98
52-Week Range ($) 1.08 - 5
Shares Outstanding (Mil) 52.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

G1 Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

G1 Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

G1 Therapeutics Inc Frequently Asked Questions

What is G1 Therapeutics Inc(GTHX)'s stock price today?
The current price of GTHX is $4.47. The 52 week high of GTHX is $5.00 and 52 week low is $1.08.
When is next earnings date of G1 Therapeutics Inc(GTHX)?
The next earnings date of G1 Therapeutics Inc(GTHX) is 2024-05-03 Est..
Does G1 Therapeutics Inc(GTHX) pay dividends? If so, how much?
G1 Therapeutics Inc(GTHX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1